RESULTS OF POSTOPERATIVE RADIATION-THERAPY IN MEDULLARY CARCINOMA OF THE THYROID - A RETROSPECTIVE STUDY BY THE FRENCH-FEDERATION-OF-CANCER-INSTITUTES - THE RADIOTHERAPY-COOPERATIVE-GROUP

被引:34
作者
NGUYEN, TD
CHASSARD, JL
LAGARDE, P
CUTULI, B
LEFUR, R
REMESAUMON, M
PREVOST, B
PANIS, X
VERRELLE, P
CHAPLAIN, G
机构
[1] CTR LEON BERARD,F-69373 LYONS,FRANCE
[2] FDN BERGONIE,F-33076 BORDEAUX,FRANCE
[3] CTR PAUL LAMARQUE,F-34033 MONTPELLIER,FRANCE
[4] CTR PAUL STRAUSS,STRASBOURG,FRANCE
[5] CTR HENRI BECQUEREL,F-76038 ROUEN,FRANCE
[6] CTR JEAN PERRIN,CLERMONT,FRANCE
[7] CTR OSCAR LAMBRET,F-59020 LILLE,FRANCE
[8] CTR GEORGES FRANCOIS LECLERC,F-21034 DIJON,FRANCE
关键词
MEDULLARY THYROID CARCINOMA; EXTERNAL RADIOTHERAPY;
D O I
10.1016/0167-8140(92)90298-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between 1971 and 1989, 59 patients received external radiation therapy with a curative intent. There were 25 females and 34 males, ranging in age from 19 to 87. No patients had distant metastasis at the onset of treatment. The majority of patients had a total thyroidectomy (55/59), generally combined with neck dissection. Residual tumour was left in 11 cases, and 44 patients had positive cervical nodes. Using megavoltage radiotherapy, the whole neck and the upper mediastinum area were most often irradiated through a large anterior Y-shaped field without laryngeal shielding. The mean dose to the tumoural bed was 54 Gy. Dysphagia was observed in 32 patients (11, 17 and 5 scores were grade 1, 2 and 3, respectively). Dyspnea occurred in five cases and in two of these cases, it was considered to be severe. Local recurrences were noted in 18 (30%) patients, most of them occurring within the fields of irradiation. Parameters such as age, sex, total dose, irradiated volumes or cervical node enlargement did not modify the local control rate. The same conclusions can be drawn for distant failures. Thirty five patients are still alive and among them, 24 have no evidence of disease. The average length of survival is 70.5 months and is shortened by the occurrence of distant failures except in patients with bone metastases.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 15 条
[2]  
CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO
[3]  
2-W
[4]  
DUH QY, 1989, ARCH SURG-CHICAGO, V124, P1206
[5]  
HARMER CL, 1977, ANN RADIOL, V20, P791
[6]  
KAGAN AR, 1977, ONCOLOGY, V29, P40
[7]  
PETURSSON SR, 1988, CANCER-AM CANCER SOC, V62, P1899, DOI 10.1002/1097-0142(19881101)62:9<1899::AID-CNCR2820620905>3.0.CO
[8]  
2-C
[9]   NONFAMILIAL MEDULLARY-THYROID CARCINOMA [J].
ROSSI, RL ;
CADY, B ;
MEISSNER, WA ;
WOOL, MS ;
SEDGWICK, CE ;
WERBER, J .
AMERICAN JOURNAL OF SURGERY, 1980, 139 (04) :554-560
[10]   MEDULLARY-THYROID CARCINOMA - PROGNOSTIC FACTORS AND TREATMENT [J].
ROUGIER, P ;
PARMENTIER, C ;
LAPLANCHE, A ;
LEFEVRE, M ;
TRAVAGLI, JP ;
CAILLOU, B ;
SCHLUMBERGER, M ;
LACOUR, J ;
TUBIANA, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (02) :161-169